![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Amgen announced that results from the PRIME ‘203’ and ‘181’ pivotal Phase 3 trials
Amgen announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating...
Bristol-Myers Squibb announced results from a randomized, double-blind Phase 3 clinical study in adults...
Bristol-Myers Squibb Company and AstraZeneca announced results from a randomized, double-blind Phase 3 clinical study...